Monitoring the ACTIVE-W trial: Some issues in monitoring a noninferiority trial
- 31 January 2008
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 155 (1) , 33-41
- https://doi.org/10.1016/j.ahj.2007.09.011
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Making Sense of Noninferiority: A Clinical and Statistical Perspective on Its Application to Cardiovascular Clinical TrialsProgress in Cardiovascular Diseases, 2007
- Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trialPublished by Elsevier ,2006
- Reporting of Noninferiority and Equivalence Randomized TrialsJAMA, 2006
- Trials and Tribulations of Non-Inferiority: The Ximelagatran ExperienceJournal of the American College of Cardiology, 2005
- A review of methods for futility stopping based on conditional powerStatistics in Medicine, 2005
- Special Invited Papers Section: Therapeutic Equivalence – Clinical Issues and Statistical Methodology in Noninferiority TrialsBiometrical Journal, 2005
- Non‐inferiority trials: design concepts and issues – the encounters of academic consultants in statisticsStatistics in Medicine, 2002
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or PlaceboNew England Journal of Medicine, 1991
- The futility index. An approach to the cost-effective termination of randomized clinical trialsThe American Journal of Medicine, 1985